Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 165

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 165
---
Certain legal matters in connection with the offering
of securities covered by this prospectus will be passed upon for us by Vinson & Elkins L.L.P. and, with respect to certain matters
of Maryland law, Venable LLP. Additional legal matters may be passed on for us, or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement.

<div align='center'>Experts</div>

The consolidated financial statements, and the
related financial statement schedule, of the Company as of December 31, 2023 and 2022, and for each of the three years in the period ended
December 31, 2023, incorporated by reference in this Prospectus by reference to the Company’s annual report on Form 10-K for the
year ended December 31, 2023, and the effectiveness of the Company’s internal control over financial reporting have been audited
by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements
and financial statement schedule have been so incorporated in reliance upon the reports of such firm given upon their authority as experts
in accounting and auditing.

<div align='center'>69

Shares

% Series B Cumulative Redeemable Preferred Stock

PRELIMINARY PROSPECTUS SUPPLEMENT</div>

| Joint Book-Running Managers |             |        |       |
| Raymond James               | BMO Capital 
 Markets     | Stifel | Baird |

<div align='center'>, 2025</div>